What is the address of QUALITY PRODUCTION?

The registered office of QUALITY PRODUCTION is located at Transportlaan 9, 3600 Genk.

Is QUALITY PRODUCTION still active?

Yes. According to the CBE (30 October 2026) QUALITY PRODUCTION is active, legal situation “Normale toestand”, started on 23 February 1987.

Is QUALITY PRODUCTION registered on Peppol?

Yes, QUALITY PRODUCTION is registered on the Peppol network with ID 0208:0430629025.

What is the enterprise number of QUALITY PRODUCTION?

The enterprise number of QUALITY PRODUCTION is BE0430629025.

When was QUALITY PRODUCTION founded?

QUALITY PRODUCTION was founded on 23 February 1987.

Who are the directors of QUALITY PRODUCTION?

According to the 2025 annual accounts, the directors of QUALITY PRODUCTION are: Spronken BV, Spronken Group NV.

Is QUALITY PRODUCTION a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 February 1987; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did QUALITY PRODUCTION make in 2025?

QUALITY PRODUCTION posted a profit after taxes of € 56,744 in financial year 2025.

What is the revenue of QUALITY PRODUCTION?

As a small company, QUALITY PRODUCTION is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,802,160.

How much does an employee at QUALITY PRODUCTION earn?

The average wage cost per full-time employee at QUALITY PRODUCTION was € 52,400 in 2025: staff costs of € 1.6 million for 31.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does QUALITY PRODUCTION have?

According to the 2025 annual accounts, QUALITY PRODUCTION has 31.2 full-time equivalents (FTE).

QUALITY PRODUCTION (Private Limited) - Genk

Q: What does QUALITY PRODUCTION do?

QUALITY PRODUCTION is registered with the CBE as active in: Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden. Private Limited, started on 23 February 1987, 1 establishment.

Dossier QUALITY PRODUCTION, printed on 30 October 2026 from databakkes.be/en/0430629025/quality-production. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

QUALITY PRODUCTION from Genk, company number BE0430629025, closed financial year 2025 with a result of € 56,744 after tax. For that financial year QUALITY PRODUCTION recorded a gross margin of € 1.8 million and equity of € 868,250. Compared with financial year 2024, the result moved from € 146,049 to € 56,744. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.

What it is worth Growing

€ 868,250

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 56,744

▼ 61% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 157,973

▲ 3% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 56,000 paid out

99 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

31.2

▲ 1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 1.6 million

▲ 4% vs 2024

€ 52,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 939,432

▲ € 901,821 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 140,432

▼ 36% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 1,962,857 Gross margin 2022: € 1,962,857 First fiscal year in the series	€ 1,644,539 Gross margin 2023: € 1,644,539 ▼ 16% vs 2022 (€ 1,962,857) Unfavourable step	€ 1,817,553 Gross margin 2024: € 1,817,553 ▲ 11% vs 2023 (€ 1,644,539) Favourable step	€ 1,802,160 Gross margin 2025: € 1,802,160 ▼ 1% vs 2024 (€ 1,817,553) Unfavourable step	▼ 1%
Profit after taxes	€ 250,299 Profit after taxes 2022: € 250,299 First fiscal year in the series	€ 7,374 Profit after taxes 2023: € 7,374 ▼ 97% vs 2022 (€ 250,299) Unfavourable step	€ 146,049 Profit after taxes 2024: € 146,049 ▲ € 138,675 vs 2023 (€ 7,374) Favourable step	€ 56,744 Profit after taxes 2025: € 56,744 ▼ 61% vs 2024 (€ 146,049) Unfavourable step	▼ 61%
Equity	€ 860,084 Equity 2022: € 860,084 First fiscal year in the series	€ 867,457 Equity 2023: € 867,457 ▲ 1% vs 2022 (€ 860,084) Favourable step	€ 867,506 Equity 2024: € 867,506 Unchanged (€ 867,457) Favourable step	€ 868,250 Equity 2025: € 868,250 Unchanged (€ 867,506) Favourable step
Total debts	€ 700,536 Total debts 2022: € 700,536 First fiscal year in the series	€ 586,003 Total debts 2023: € 586,003 ▼ 16% vs 2022 (€ 700,536) Favourable step	€ 465,742 Total debts 2024: € 465,742 ▼ 21% vs 2023 (€ 586,003) Favourable step	€ 1,150,384 Total debts 2025: € 1,150,384 ▲ 147% vs 2024 (€ 465,742) Unfavourable step	▲ 147%
Cash	€ 257,275 Cash 2022: € 257,275 First fiscal year in the series	€ 745,154 Cash 2023: € 745,154 ▲ 190% vs 2022 (€ 257,275) Favourable step	€ 153,645 Cash 2024: € 153,645 ▼ 79% vs 2023 (€ 745,154) Unfavourable step	€ 157,973 Cash 2025: € 157,973 ▲ 3% vs 2024 (€ 153,645) Favourable step	▲ 3%
Land & buildings	€ 321 Land & buildings 2022: € 321 First fiscal year in the series	-	-	-
Retained profit	€ 847,276 Retained profit 2022: € 847,276 First fiscal year in the series	€ 854,649 Retained profit 2023: € 854,649 ▲ 1% vs 2022 (€ 847,276) Favourable step	€ 854,698 Retained profit 2024: € 854,698 Unchanged (€ 854,649) Favourable step	€ 855,442 Retained profit 2025: € 855,442 Unchanged (€ 854,698) Favourable step
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 146,000 Dividend 2024: € 146,000 Unchanged (€ 0) Unchanged	€ 56,000 Dividend 2025: € 56,000 ▼ 62% vs 2024 (€ 146,000) Unchanged	▼ 62%
Balance sheet total	€ 1,560,620 Balance sheet total 2022: € 1,560,620 First fiscal year in the series	€ 1,453,460 Balance sheet total 2023: € 1,453,460 ▼ 7% vs 2022 (€ 1,560,620) Unchanged	€ 1,333,249 Balance sheet total 2024: € 1,333,249 ▼ 8% vs 2023 (€ 1,453,460) Unchanged	€ 2,018,635 Balance sheet total 2025: € 2,018,635 ▲ 51% vs 2024 (€ 1,333,249) Unchanged	▲ 51%
Employees (FTE)	31.8 Employees (FTE) 2022: 31.8 First fiscal year in the series	32.5 Employees (FTE) 2023: 32.5 ▲ 0.7 vs 2022 (31.8) Unchanged	30.2 Employees (FTE) 2024: 30.2 ▼ 2.3 vs 2023 (32.5) Unchanged	31.2 Employees (FTE) 2025: 31.2 ▲ 1 vs 2024 (30.2) Unchanged	▲ 1

Key figures of QUALITY PRODUCTION, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to QUALITY PRODUCTION?

What happened at QUALITY PRODUCTION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2031 Spronken BV stepped down as director. NBB
2031 Spronken Group NV stepped down as director. NBB
Aug 25, 2026 New annual accounts for financial year 2025: profit of € 56,744 (▼ 61% vs 2024). filed late Source: NBB ↗
2025 Spronken BV became a director. NBB
2025 Spronken Group NV became a director. NBB
Jun 10, 1999 New establishment in Genk. KBO
Feb 23, 1987 Start of the company according to the CBE. KBO

In short

From € 250,299 profit in 2022 to € 56,744 profit in 2025.

Paid € 199,866 in corporate taxes since 2022.

Best year ever: 2022, with € 250,299 profit.

On average € 57,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Spronken BV

Director · represented by Maria Spronken

Also active at: SPRONKEN ORTHOPEDIE, SPROTECH, BELGO-INTERNATIONAL RESEARCH APPLICATIONS en DEVELOPMENT, MEDFAC, SPRONKEN GROUP, ORTHO MEDICA, I'MMSPRO

since 2025 · until 2031

Spronken Group NV

Director · represented by Caius Spronken

Also active at: SPRONKEN ORTHOPEDIE, SPROTECH, BELGO-INTERNATIONAL RESEARCH APPLICATIONS en DEVELOPMENT, SPRONKEN, I'MMSPRO

since 2025 · until 2031

Establishments

Establishment units

Physical locations of this company

Registered office

Transportlaan 9

3600 Genk

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.

All companies at this address →

SPRONKEN ORTHOPEDIE same network

€ 16.3 million revenue · 2025

MEDFAC same network

€ -11,357 gross margin · 2025

SPRONKEN GROUP same network

€ 1 million gross margin · 2025

ORTHO MEDICA same network

€ -1,845 gross margin · 2025

SPRONKEN same network

€ 55,540 gross margin · 2025

+1 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0430.629.025

VAT number

BE 0430.629.025

Registered office

Transportlaan 9, 3600 Genk

Names & denominations

QUALITY PRODUCTION

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

23 February 1987

Peppol

Active · Active since 14 Nov 2025

Activities · NACE

Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden

Groothandel in parfumerieën en cosmetica

View on CBE Public ↗ Annual accounts (NBB) ↗